Meeting Program

 

The meeting program is currently in development. Session topics are outlined below and details will be added as they become available.

 

Plenary Sessions

Four general sessions will be available for all attendees.

 

Past, Present and Future Development in Pharmacogenomics

The Need for Complex Cellular Models

Nanotechnologies Enabling Drug Delivery

Predictive Risk Scores: Patient Empowerment

 

Parallel Sessions

Attendees can choose from these twelve parallel sessions.

 

Implementation of Pharmacogenomic Testing

Stem Cell-based in vitro Systems to Assess Drug Safety, Drug Discovery and Development

New Developments in Therapeutic Drug Monitoring (TDM)

The Use of Artificial Intelligence and Machine Learning in Drug Discovery and Development

Pharmacogenomics, Drug Development and Regulatory Aspects

Novel, Human in vitro Models to Study Diseases and Mechanisms

Emerging Topics in the Field of Drug Transporters

Impact of New Drug Delivery Methodologies on ADME and Safety

Transporter-mediated Drug-drug Interactions and Translation from in vitro to Clinics

New Modalities - New Challenges

Drug-drug Interactions from the Model to the Clinic

Challenges in Today's Drug Research and Development - The Regulator's View

Microphysiological Systems: Current Status and Applications

Current Approaches and Limitations in the Assessment of Drug-induced Liver Injury (DILI)

Drivers of Modern Drug Development

 

Optional Short Courses

Short courses will be held on Sunday, June 7 and may be added to attendee registrations for an additional fee. Course attendees will receive digital access to course materials and lunch will be provided to all course registrants.

 

-Omics Technologies Basic Aspects and Potential Applications

PBPK

Educating Tomorrow's Scientists and Clinicians in Pharmacogenomics and Personalized Therapy